Xeris Pharmaceuticals Secures $7,274,592 Series B Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c027e1b5-8ee3-4f0b-ae1a-a977f87b8270
Date
9/29/2014
Company Name
Xeris Pharmaceuticals
Mailing Address
3208 Red River Street Austin, TX 78705 USA
Company Description
Xeris is an Austin, Texas-based specialty pharmaceutical company developing patient-friendly injectables for indications in diabetes, epilepsy, and immunology.
Website
http://www.xerispharma.com
Transaction Type
Venture Equity
Transaction Amount
$7,274,592
Transaction Round
Series B
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
M&A Terms
Venture Investor